
Maya Patel
Analyst
Can Hansoh Pharmaceutical Monetize Its Expanding Drug Portfolio?
Hansoh Pharmaceutical Group Company Limited's growth from new drug development is translating into stronger earnings, though future returns depend on continued pipeline success.
June 30, 2026 at 03:07 pm IST
Can Emami's Growth Hold Amid Margin Pressure?
Emami Limited's story is a mix of steady brands and evolving bets. While recent performance has been a bit soft and the stock has taken a hit, its strong rural base and premium push in cities keep its long-term growth story interesting, with it worth watching.
June 16, 2026 at 01:05 pm IST

Rasan Information Technology Benefiting from Stronger Growth
Rasan Information Technology Company's been on a strong run, with its stock climbing alongside solid earnings, mainly powered by its fast-growing motor leasing business. However, rising geopolitical tensions are increasing economic uncertainty, market volatility and financial pressures in the region, which could make execution more challenging henceforth.
June 08, 2026 at 02:26 pm IST

Ansell Transforms Steady Revenue into Strong Earnings
Ansell Limited is riding a steady safety-driven demand wave, although its recent performance is more reliant on pricing and efficiency rather than real volume growth. The stock is up, but still below its peak; will demand catch up?
May 26, 2026 at 02:41 pm IST
Discover our authors
Chief Editor
Senior Analyst
Journalist
Journalist
Analyst
- Stock Market
- Our authors
- Maya Patel

























